For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 1a - Pilot/Safety: Dosing Interval on Days: 1 | Participants received 1 dose of 4x10\^5 PfSPZ via direct venus inoculation (DVI) with 75 mg PYR day 0 post PfSPZ | 0 | None | 0 | 4 | 1 | 4 | View |
| 1b - Safety/Efficacy: Dosing Interval on Days: 1, 29, 57 | Participants received 4x10\^5 PfSPZ via direct venus inoculation (DVI) with 75 mg PYR day 0 post PfSPZ on day 1, day 29 and day 57. | 1 | None | 1 | 90 | 88 | 90 | View |
| 2a - Pilot/Safety: Dosing Interval on Days: 1 | Participants received 1 dose of 4x10\^5 PfSPZ via direct venus inoculation (DVI) with 75 mg PYR day 2 \& 3 post PfSPZ | 0 | None | 0 | 4 | 1 | 4 | View |
| 2b - Safety/Efficacy: Dosing Interval on Days: 1, 29, 57 | Participants received 4x10\^5 PfSPZ via direct venus inoculation (DVI) with 75 mg PYR day 2 \& 3 post PfSPZ on day 1, day 29 and day 57. | 0 | None | 0 | 60 | 59 | 60 | View |
| 3a - Pilot/Safety: Dosing Interval on Days: 1 | Participants received 1 dose of 4x10\^5 PfSPZ via direct venus inoculation (DVI) with chloroquine 2 days prior \& 5 days post PfSPZ | 0 | None | 0 | 4 | 2 | 4 | View |
| 4a - Safety Comparator: Dosing Interval on Days: 1, 29, 57 | Participants received normal saline (NS) via direct venus inoculation (DVI) with 75 mg PYR day 0 post PfSPZ on day 1, day 29 and day 57. | 0 | None | 1 | 54 | 51 | 54 | View |
| 4b - Safety Comparator: Dosing Interval on Days: 1, 29, 57 | Participants received normal saline (NS) via direct venus inoculation (DVI) with 75 mg PYR day 2 \& 3 post PfSPZ on day 1, day 29 and day 57. | 0 | None | 0 | 36 | 36 | 36 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Accident at home | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Arthropod sting | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Blood creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Breast pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Bronchitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Candidiasis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Conjunctivitis | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Decreased appetite | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Dental caries | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dermatosis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dysentery | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Ear infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Ecchymosis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Enteritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Eye burns | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Eye injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Food poisoning | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Forearm fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Fungal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Furuncle | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Gastritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastroenteritis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Genital infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Genitourinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Hemoglobin decreased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Hemorrhoids | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Influenza | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Inguinal hernia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Injection site oedema | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injection site pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Intercostal neuralgia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Joint dislocation | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Leukopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Limb injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Malaise | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Malaria | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Nasopharyngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Oropharyngeal pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Otitis media | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Parasitic gastroenteritis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Paronychia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pyoderma | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Rhinitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sciatica | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Sinobronchitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Strangulated umbilical hernia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Systolic hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Tonsillitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Tooth abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Typhoid fever | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urticaria | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Vaginal haemorrhage | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Varicella | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Vertigo | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Vessel puncture site pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Volvulus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| White blood cell count increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Wound | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |